INFRATIL LIMITED (IFT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IFT

IFT - INFRATIL LIMITED

FNArena Sector : Wealth Management & Investments
Year End: March
GICS Industry Group : Capital Goods
Debt/EBITDA: 9.94
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$12.39

08 Jul
2026

-0.250

OPEN

$12.59

-1.98%

HIGH

$12.59

257,903

LOW

$12.26

TARGET
$14.49 16.9% upside
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CGF . CVW . DJW . ENN . GDG . GQG . HMC . HUB . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
IFT: 1
Title FY27
Forecast		 FY28
Forecast
EPS (cps) 10.4 xxx
DPS (cps) 14.2 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 120.9 xxx
Dividend Yield 1.1% xxx
Div Pay Ratio(%) 136.7% xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 1.84%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 1.37

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/11 - (franking ex-div 8c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx49.6
DPS All xxxxxxxxxxxxxxx19.3
Sales/Revenue xxxxxxxxxxxxxxx2,617.4 M
Book Value Per Share xxxxxxxxxxxxxxx639.9
Net Operating Cash Flow xxxxxxxxxxxxxxx173.3 M
Net Profit Margin xxxxxxxxxxxxxxx9.15 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx3.85 %
Return on Invested Capital xxxxxxxxxxxxxxx1.96 %
Return on Assets xxxxxxxxxxxxxxx1.50 %
Return on Equity xxxxxxxxxxxxxxx3.85 %
Return on Total Capital xxxxxxxxxxxxxxx1.07 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-344.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx617 M
Long Term Debt xxxxxxxxxxxxxxx5,979 M
Total Debt xxxxxxxxxxxxxxx6,596 M
Goodwill - Gross xxxxxxxxxxxxxxx3,937 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx260 M
Price To Book Value xxxxxxxxxxxxxxx1.52

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx489.3 M
Capex % of Sales xxxxxxxxxxxxxxx18.69 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,819 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx651 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,494 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

27/05/2026

2

Accumulate

$13.80

11.38%

Morgans views Infratil's FY26 was robust with net proportionate earnings (EBITDA) rising 11% y/y and above guidance by 4%.

Proportionate capex came in above expectations, up 17% y/y and is flagged to rise around 57% in FY27 with management recycling capital to reinvest in growth assets, the analyst explains.

CDC generated AU$393m of earnings (EBITDA) and is anticipated to reach around AU$700m in FY27 and over AU$1bn in FY28 (100% of CDC) with Infratil owning 49.75%.

The broker highlights data centres, including CDC were the main earnings drivers but renewables are expected to be a major contributor going forward.

Morgans forecasts the net asset value per share post fees rose 4% and the target price rises to $13.80 from $11.30, a -10% discount to NAV.

Accumulate rating retained.

FORECAST
Morgans forecasts a full year FY27 dividend of 18.04 cents.
Morgans forecasts a full year FY28 dividend of 18.04 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

11/05/2026

1

Buy

-

-

Jarden retains a Buy rating and unchanged NZ$14.56 target price for Infratil Limited following the announcement of a massive 555MW data centre contract secured by its (not fully owned) CDC Data Centres business.

The 30-year agreement with an investment-grade US customer represents the largest data contract in Australian history and pushes CDC's total contracted capacity beyond 1GW.

Earnings contributions from the new capacity will commence as operations scale across FY28 and FY29, the report explains, supported by the company's existing development program.

Management reaffirmed FY27 EBITDAF guidance of A$680m to A$720m while forecasting a step-change in earnings to exceed A$1bn in FY28.

The broker views the scale of this contract as a major validation of the underlying investment thesis, projecting annualised EBITDAF to approach A$2bn once fully deployed.
Access Extra Coverage Research History >

IFT STOCK CHART

FNArena News on IFT

1
Rudi’s View: Best Buys & Conviction Calls In July

Jul 02 2026 - Rudi's View
2
Rudi’s View: The August Results Test Awaits

Jul 01 2026 - Rudi's View
3
Rudi’s View: Diversified Asset Allocators

Jun 11 2026 - Rudi's View
4
In Brief: Maritana, Tasmea & SRG Global

Jun 05 2026 - Weekly Reports
5
Rudi’s View: Australia’s Sh*t Sandwich

Jun 04 2026 - Rudi's View

Latest Wealth Management & Investments News

1
Treasure Chest: ASX

Jul 08 2026 - Treasure Chest
2
Weekly Update On LICs & LITs – 07-Jul-2026

Jul 07 2026 - Weekly Reports
3
Weekly Update On LICs & LITs – 30-Jun-2026

Jun 30 2026 - Weekly Reports
4
Weekly Update On LICs & LITs – 22-Jun-2026

Jun 23 2026 - Weekly Reports
5
Weekly Update On LICs & LITs – 15-Jun-2026

Jun 16 2026 - Weekly Reports
6
Downside Risk For SGH

Jun 16 2026 - Technicals
7
Weekly Update On LICs & LITs – 10-Jun-2026

Jun 11 2026 - Weekly Reports
8
Weekly Update On LICs & LITs – 03-Jun-2026

Jun 03 2026 - Weekly Reports
9
CDC, Renewables Power Infratil’s Potential

May 28 2026 - Australia
10
Weekly Update On LICs & LITs – 27-May-2026

May 27 2026 - Weekly Reports